Recent findings indicate that the main factor underlying the development and progression of AD is tau, not Aβ and to delay the course of AD, the downstream neuropathological processes like tau phosphorylation and aggregation, as well as (maybe) oxidative stress and inflammation [91], must be controlled. The gene discussed is MAPT; the disease is Alzheimer disease.